search
Back to results

Effect of App-driven Deep Breathing (NEURODIGITX) on Anxiety Levels and Quality of Life in Caregivers (DIAL_X)

Primary Purpose

Anxiety Disorders, Hospital Workers, Deep Breath

Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
NeurodigitX
Control
Sponsored by
Fondation Hôpital Saint-Joseph
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Anxiety Disorders

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Healthcareworkers whose age ≥ 18 years, Healthcareworkers working in the Emergency Department, Intensive Care Unit and/or visiting the Bulle at least once a week (frequency assessed by Delphi method) at Hôpital Paris Saint-Joseph, healthcareworkers visiting the Bulle at Hôpital Marie-Lannelongue at least once a week and healthcareworkers working at Hôpital Sainte-Marie or Hôpital Léopold Bellan French speaking staff Staff affiliated to the social security system or, failing that, to another health insurance system Staff who have given their free, informed and written consent Exclusion Criteria: Current participation in another interventional study regarding post-traumatic stress or anxiety Regular practice in the last year of deep breathing techniques in the context of anxiety management (meditation, cardiac coherence, etc.) Use of medications that slow down the heart rate: antiarrhythmics, calcium channel blockers, beta-blockers.

Sites / Locations

  • Hôpital Marie Lannelongue
  • Hôpital Léopold BELLAN
  • Hôpital Paris Saint-Joseph
  • Hôpital Sainte-Marie

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

NeurodigitX

Control

Arm Description

After randomization, the "NeurodigitX Group" receiving this program will follow the recommendations for a period of three months (2 sessions of 2 minutes per day). At this visit and at the 1/2/3 and 6 month visits, staff will complete the following scales and questionnaires (15 minutes in length): Visual Anxiety Analog Scale (VAS), Spielberger Anxiety Scale - State (STAI form Y-A) and SF-12 Quality of Life Questionnaire. All participants will be called in at 3 months for a visit to measure HRV via the app.

After randomization, the "Control Group" does not receive the NeurodigitX application. At this visit and at the 1/2/3 and 6 month visits, staff will complete the following scales and questionnaires (15 minutes in length): Visual Anxiety Analog Scale (VAS), Spielberger Anxiety Scale - State (STAI form Y-A) and SF-12 Quality of Life Questionnaire. All participants will be called in at 3 months for a visit to measure HRV via the app.

Outcomes

Primary Outcome Measures

Effect of a 3-month program of regular deep breathing practice on anxiety
This outcome corresponds to the comparison of the evolution of anxiety scores between the 2 groups NeuroDigitX and Control, by Spielberger's State-Trait Anxiety Inventory. Each response to a STAI item is scored from 1 to 4, with 1 indicating the lowest degree of anxiety and 4 the highest. For the AE and AT scales, there are 10 and 9 items respectively. To obtain the AE score, the scores obtained on the 20 items corresponding to AE (items 1 to 20) are added together.

Secondary Outcome Measures

Effect of the program on quality of life at 3 month
This outcome corresponds to the comparison of changes in quality of life scores. The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure. The SF-12 is a shortened version of it's predecessor, the SF-36, which itself evolved from the Medical Outcomes Study. The SF-12 was created to reduce the burden of response.
Effect of the program on quality of life at 6 month
This outcome corresponds to the comparison of changes in quality of life scores.The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure. The SF-12 is a shortened version of it's predecessor, the SF-36, which itself evolved from the Medical Outcomes Study. The SF-12 was created to reduce the burden of response.
Effect of the program on the evolution of heart rate variability at 3 month
This outcome corresponds to the comparison of changes in heart rate variability measurements between the 2 groups at 3 months.
Effect of the program by profession and department (emergency, intensive care, other department)
This outcome corresponds to the comparison of measures of anxiety according to the occupation and service of the volunteers.
Effect of the program by profession and department (emergency, intensive care, other department)
This outcome corresponds to the comparison of measures of anxiety according to the occupation and service of the volunteers. Spielberger's State-Trait Anxiety Inventory: Each response to a STAI item is scored from 1 to 4, with 1 indicating the lowest degree of anxiety and 4 the highest. For the AE and AT scales, there are 10 and 9 items respectively. To obtain the AE score, the scores obtained on the 20 items corresponding to AE (items 1 to 20) are added together.

Full Information

First Posted
February 24, 2023
Last Updated
September 11, 2023
Sponsor
Fondation Hôpital Saint-Joseph
search

1. Study Identification

Unique Protocol Identification Number
NCT05771909
Brief Title
Effect of App-driven Deep Breathing (NEURODIGITX) on Anxiety Levels and Quality of Life in Caregivers
Acronym
DIAL_X
Official Title
Effect of App-driven Deep Breathing (NEURODIGITX) on Anxiety Levels and Quality of Life in Caregivers: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 30, 2023 (Anticipated)
Primary Completion Date
November 29, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondation Hôpital Saint-Joseph

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The occurrence of the COVID-19 pandemic is associated with an increase in psychiatric illnesses (depression, anxiety) in the general population due to the infectious and vital risk involved, changes in social structure, particularly in the family environment, episodes of confinement, and even professional instability. These international phenomena have also been observed in France. In addition to the constraints of the general population, health care workers have been, and continue to be, subject to other forms of constraints, linked to their professional activity. Indeed, the risk of viral exposure is for them major, the confrontation with the deaths of patients because of their fragility or the weakness of the care structures, are more violent in connection with their immediate reality. In addition, the workload due to health imperatives has also led to physical and psychological exhaustion of the health care teams. In addition to the international evidence, the existence and severity of the psychological consequences for health care workers have recently been documented at the local level in a survey conducted among the staff of the Groupe hospitalier Paris Saint-Joseph (GhPSJ). In this study of more than 780 people, nearly half of whom were in charge of patients infected with SARS-CoV2, 62% reported increased anxiety since the beginning of the epidemic, 41% had symptoms of anxiety, 21% had symptoms of depression and 14% had signs of post-traumatic stress. Approximately 25% of the total population had chosen to make regular use of the "bulle" (a decompression and care platform made available to staff since the first wave within the establishment) with the aim of reducing the anxiety generated by the situation and particularly by their professional activity. Given the importance of anxiety symptoms detected in healthcare professionals during the COVID-19 pandemic, the use of a simple, brief technique, requiring neither trained personnel nor expensive or difficult-to-access devices, aimed at reducing anxious stress could be of significant benefit to the population, especially to caregivers. The objective of this study is to measure the effect of deep breathing on the anxiety of health professionals in the aftermath of the COVID-19 pandemic, and its effect on their quality of life. In order to measure the quality of the sessions, the breathing movements will be performed using a calibrated program and their immediate effectiveness will be evaluated by the variation of the heart rate, visible just after the program by the user. The NeurodigitX® system offers to control interactive 3D games on a smartphone application through breath via a sensor connected to the phone by Bluetooth. This tool also allows to measure by plethysmography the heart rate variability in a simple and non-invasive way. This system has been created as a preventive health solution by allowing everyone to measure, compare and share the activity of their Autonomic Nervous System (ANS) to better predict, understand, prevent and treat certain chronic diseases.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety Disorders, Hospital Workers, Deep Breath

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
160 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
NeurodigitX
Arm Type
Experimental
Arm Description
After randomization, the "NeurodigitX Group" receiving this program will follow the recommendations for a period of three months (2 sessions of 2 minutes per day). At this visit and at the 1/2/3 and 6 month visits, staff will complete the following scales and questionnaires (15 minutes in length): Visual Anxiety Analog Scale (VAS), Spielberger Anxiety Scale - State (STAI form Y-A) and SF-12 Quality of Life Questionnaire. All participants will be called in at 3 months for a visit to measure HRV via the app.
Arm Title
Control
Arm Type
Other
Arm Description
After randomization, the "Control Group" does not receive the NeurodigitX application. At this visit and at the 1/2/3 and 6 month visits, staff will complete the following scales and questionnaires (15 minutes in length): Visual Anxiety Analog Scale (VAS), Spielberger Anxiety Scale - State (STAI form Y-A) and SF-12 Quality of Life Questionnaire. All participants will be called in at 3 months for a visit to measure HRV via the app.
Intervention Type
Other
Intervention Name(s)
NeurodigitX
Intervention Description
The "NeurodigitX Group" receiving this program will follow the recommendations for a period of three months (2 sessions of 2 minutes per day).
Intervention Type
Other
Intervention Name(s)
Control
Intervention Description
The "Control Group" does not receive the NeurodigitX application.
Primary Outcome Measure Information:
Title
Effect of a 3-month program of regular deep breathing practice on anxiety
Description
This outcome corresponds to the comparison of the evolution of anxiety scores between the 2 groups NeuroDigitX and Control, by Spielberger's State-Trait Anxiety Inventory. Each response to a STAI item is scored from 1 to 4, with 1 indicating the lowest degree of anxiety and 4 the highest. For the AE and AT scales, there are 10 and 9 items respectively. To obtain the AE score, the scores obtained on the 20 items corresponding to AE (items 1 to 20) are added together.
Time Frame
Month 3
Secondary Outcome Measure Information:
Title
Effect of the program on quality of life at 3 month
Description
This outcome corresponds to the comparison of changes in quality of life scores. The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure. The SF-12 is a shortened version of it's predecessor, the SF-36, which itself evolved from the Medical Outcomes Study. The SF-12 was created to reduce the burden of response.
Time Frame
Month 3
Title
Effect of the program on quality of life at 6 month
Description
This outcome corresponds to the comparison of changes in quality of life scores.The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure. The SF-12 is a shortened version of it's predecessor, the SF-36, which itself evolved from the Medical Outcomes Study. The SF-12 was created to reduce the burden of response.
Time Frame
Month 6
Title
Effect of the program on the evolution of heart rate variability at 3 month
Description
This outcome corresponds to the comparison of changes in heart rate variability measurements between the 2 groups at 3 months.
Time Frame
Month 3
Title
Effect of the program by profession and department (emergency, intensive care, other department)
Description
This outcome corresponds to the comparison of measures of anxiety according to the occupation and service of the volunteers.
Time Frame
Day 1
Title
Effect of the program by profession and department (emergency, intensive care, other department)
Description
This outcome corresponds to the comparison of measures of anxiety according to the occupation and service of the volunteers. Spielberger's State-Trait Anxiety Inventory: Each response to a STAI item is scored from 1 to 4, with 1 indicating the lowest degree of anxiety and 4 the highest. For the AE and AT scales, there are 10 and 9 items respectively. To obtain the AE score, the scores obtained on the 20 items corresponding to AE (items 1 to 20) are added together.
Time Frame
Month 6

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Healthcareworkers whose age ≥ 18 years, Healthcareworkers working in the Emergency Department, Intensive Care Unit and/or visiting the Bulle at least once a week (frequency assessed by Delphi method) at Hôpital Paris Saint-Joseph, healthcareworkers visiting the Bulle at Hôpital Marie-Lannelongue at least once a week and healthcareworkers working at Hôpital Sainte-Marie or Hôpital Léopold Bellan French speaking staff Staff affiliated to the social security system or, failing that, to another health insurance system Staff who have given their free, informed and written consent Exclusion Criteria: Current participation in another interventional study regarding post-traumatic stress or anxiety Regular practice in the last year of deep breathing techniques in the context of anxiety management (meditation, cardiac coherence, etc.) Use of medications that slow down the heart rate: antiarrhythmics, calcium channel blockers, beta-blockers.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marguerite D'USSEL, MD
Phone
1 44 12 71 47
Ext
+33
Email
mdussel@ghpsj.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Francois PHILIPPART, MD
Phone
1 44 12 70 21
Ext
+33
Email
fphilippart@ghpsj.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marguerite D'USSEL, MD
Organizational Affiliation
Fondation Hôpital Saint-Joseph
Official's Role
Study Director
Facility Information:
Facility Name
Hôpital Marie Lannelongue
City
Le Plessis-Robinson
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marguerite D'USSEL, MD
First Name & Middle Initial & Last Name & Degree
Carmen Credico, MD
Facility Name
Hôpital Léopold BELLAN
City
Paris
ZIP/Postal Code
75014
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bernard Durand Gasselin, MD
Email
bernard.durand-gasselin@fondationbellan.org
Facility Name
Hôpital Paris Saint-Joseph
City
Paris
ZIP/Postal Code
75014
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marguerite D'USSEL, MD
Phone
1 44 12 71 47
Ext
+33
Email
mdussel@ghpsj.fr
First Name & Middle Initial & Last Name & Degree
Francois PHILIPPART, MD
Phone
144127021
Ext
+33
Email
fphilippart@ghpsj.fr
Facility Name
Hôpital Sainte-Marie
City
Paris
ZIP/Postal Code
75014
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Florence BONTE, MD
Email
florence.bonte@idf.vyv3.fr

12. IPD Sharing Statement

Citations:
PubMed Identifier
32853913
Citation
Casagrande M, Favieri F, Tambelli R, Forte G. The enemy who sealed the world: effects quarantine due to the COVID-19 on sleep quality, anxiety, and psychological distress in the Italian population. Sleep Med. 2020 Nov;75:12-20. doi: 10.1016/j.sleep.2020.05.011. Epub 2020 May 12.
Results Reference
background
PubMed Identifier
32466251
Citation
Choi EPH, Hui BPH, Wan EYF. Depression and Anxiety in Hong Kong during COVID-19. Int J Environ Res Public Health. 2020 May 25;17(10):3740. doi: 10.3390/ijerph17103740.
Results Reference
background
PubMed Identifier
32326997
Citation
Dutheil F, Mondillon L, Navel V. PTSD as the second tsunami of the SARS-Cov-2 pandemic. Psychol Med. 2021 Jul;51(10):1773-1774. doi: 10.1017/S0033291720001336. Epub 2020 Apr 24.
Results Reference
background
PubMed Identifier
32374806
Citation
Ozamiz-Etxebarria N, Dosil-Santamaria M, Picaza-Gorrochategui M, Idoiaga-Mondragon N. Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain. Cad Saude Publica. 2020 Apr 30;36(4):e00054020. doi: 10.1590/0102-311X00054020. eCollection 2020. English, Spanish.
Results Reference
background
PubMed Identifier
32569360
Citation
Serafini G, Parmigiani B, Amerio A, Aguglia A, Sher L, Amore M. The psychological impact of COVID-19 on the mental health in the general population. QJM. 2020 Jun 22;113(8):531-7. doi: 10.1093/qjmed/hcaa201. Online ahead of print.
Results Reference
background
PubMed Identifier
35482772
Citation
d'Ussel M, Fels A, Durand X, Lemogne C, Chatellier G, Castreau N, Adam F. Factors associated with psychological symptoms in hospital workers of a French hospital during the COVID-19 pandemic: Lessons from the first wave. PLoS One. 2022 Apr 28;17(4):e0267032. doi: 10.1371/journal.pone.0267032. eCollection 2022.
Results Reference
background
PubMed Identifier
35859769
Citation
d'Ussel M, Adam F, Fels A, Chatellier G, Philippart F. Characteristics of Hospital Workers Using a Wellbeing Center Implemented During the COVID-19 Pandemic to Prevent the Emotional Impacts of the Crisis. Front Public Health. 2022 Jul 4;10:913126. doi: 10.3389/fpubh.2022.913126. eCollection 2022.
Results Reference
background
PubMed Identifier
32961219
Citation
Lefevre H, Stheneur C, Cardin C, Fourcade L, Fourmaux C, Tordjman E, Touati M, Voisard F, Minassian S, Chaste P, Moro MR, Lachal J. The Bulle: Support and Prevention of Psychological Decompensation of Health Care Workers During the Trauma of the COVID-19 Epidemic. J Pain Symptom Manage. 2021 Feb;61(2):416-422. doi: 10.1016/j.jpainsymman.2020.09.023. Epub 2020 Sep 19.
Results Reference
background

Learn more about this trial

Effect of App-driven Deep Breathing (NEURODIGITX) on Anxiety Levels and Quality of Life in Caregivers

We'll reach out to this number within 24 hrs